越南介入心脏病学市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

越南介入心脏病学市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Upcoming Report
  • Feb 2024
  • Country Level
  • 350 页面
  • 桌子數: 220
  • 图号: 60

越南介入心脏病学市场,按产品(导丝、导管、冠状动脉支架、血管成形术球囊、血管闭合装置 (VCD)、血管内超声 (IVUS)、血流动力学流量改变装置、斑块修改装置、血流储备分数 (FFR)、配件)、类型(常规、高级)、适应症(心导管插入术、经皮冠状动脉介入治疗 (PCI)、冠状动脉血栓切除术、动脉粥样硬化斑块切除术、球囊成形术、支架植入术、低温/主动脉内球囊泵、卵圆孔未闭闭合术、其他)、年龄(成人、儿童、老年人)、最终用户(医院、导管实验室、学术和研究机构、其他)、分销渠道(直接招标、第三方分销商、零售)– 行业趋势和预测到 2031 年。

越南介入心脏病学市场分析及规模

全球心血管疾病的高发性和老年人口的增长促进了介入心脏病学市场的增长。然而,高昂的成本可能会阻碍市场的增长。医疗保健支出的增加预计将为市场对介入心脏病学设备的需求增长提供机会。对心血管疾病及其干预措施的认识不足预计将对介入心脏病学市场的增长构成挑战。 

Data Bridge Market Research 分析,越南介入心脏病学市场规模在 2023 年为 5477 万美元,到 2031 年可能达到 9270 万美元,预计在 2024-2031 年预测期内的复合年增长率为 6.80%。导管在介入心脏病学市场的产品领域中占据主导地位,因为这些导管用于诊断和治疗程序,因此具有很高的消费和使用率。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按产品(导丝、导管、冠状动脉支架、血管成形术球囊、血管封堵装置 (VCD)、血管内超声(IVUS)、血流动力学流量改变装置、斑块修改装置、血流储备分数 (FFR)、配件)、类型(常规、高级)、适应症(心导管插入术、经皮冠状动脉介入治疗 (PCI)、冠状动脉血栓切除术、动脉粥样硬化斑块切除术、球囊血管成形术、支架植入术、低温/主动脉内球囊泵、卵圆孔未闭封堵术、其他)、年龄(成人、儿童、老年人)、最终用户(医院、导管实验室、学术和研究机构、其他)、分销渠道(直接投标、第三方分销商、零售)

覆盖国家

越南

涵盖的市场参与者

Medtronic(爱尔兰)、Teleflex Incorporated(美国)、Terumo Vietnam Medical Equipment Co., Ltd(Terumo Corporation 的子公司)(日本)、Abbott(美国)、Boston Scientific Corporation(美国)、B. Braun Melsungen AG(德国)、USM HEALTHCARE(新加坡)、BIOTRONIK(德国)、Stryker(美国)、Philips Electronics NV(Koninjlkjke Philps NV 的子公司)(荷兰)、BD(美国)、Medinol Ltd.(以色列)、AngioDynamics(美国)

市场机会

  • 心脏手术数量不断增加
  • 心血管疾病发病率不断上升

市场定义

介入心脏病学是心脏病学的一个领域,其中导管用于诊断和治疗心脏病。介入心脏病学中使用的导管是一种长管状柔性器械,通过手臂桡动脉、腹股沟或颈部股动脉的血管插入并穿入心脏。通过这种方式,可以评估个人的心脏状况,修复受损的心脏瓣膜,或疏通堵塞的动脉。介入心脏病学的一些程序包括心导管插入术、冠状动脉成形术、球囊瓣膜成形术、冠状动脉血栓切除术和心脏消融术。            

介入心脏病学市场动态

驱动程序

  • 心血管疾病负担加重 

越南心血管疾病 (CVD) 发病率的上升是介入心脏病学市场的重要推动力。生活方式、饮食习惯的改变和人口老龄化等因素导致 CVD 患病率上升。这推动了对介入心脏病学手术的需求,包括血管成形术和支架置入术。

  • 医疗技术的进步

介入心脏病学的技术进步,包括创新设备的开发、导管插入技术的改进以及微创手术,使治疗更加有效和安全。这些创新吸引了患者和医疗保健提供者,并推动了市场增长。

  • 政府举措和医疗保健投资

政府在医疗保健领域的举措和投资在支持越南介入心脏病学的发展方面发挥着至关重要的作用。增加对医疗保健基础设施的资金、为医疗专业人员提供培训计划以及努力扩大先进心脏护理设施的使用范围,都有助于市场扩张。

  • 医疗设施投资不断增加

人们对改善医疗设施状况和改善整体医疗基础设施的关注度不断上升,这是促进市场增长的另一个重要因素。公共和私营企业之间在资助和应用新技术和改进技术方面建立的伙伴关系和战略合作不断增多,进一步创造了有利可图的市场机会。  

机会

  • 微创手术需求不断增长

在越南,人们越来越倾向于微创手术,因为这种手术可以缩短恢复时间、减少住院时间并减轻患者的不适。这一趋势为介入心脏病学提供者提供了提供一系列微创治疗的机会,例如血管成形术和经导管主动脉瓣置换术 (TAVR),以满足日益增长的需求。

  • 与制药公司的合作

介入心脏病学提供商与制药公司之间的合作可以促进心血管疾病综合治疗方法的发展。这包括将介入程序与药物干预相结合,为患者提供整体护理,并提供市场扩展机会。

限制

  • 获得专科护理的机会有限

在越南,获得专业介入性心脏病治疗的机会有限,尤其是在农村地区。先进的心脏护理设施集中在城市中心,导致医疗保健机会的不平等。这一限制可能会限制介入性心脏病服务覆盖更广泛的人群。

  • 成本和可负担性

介入性心脏病治疗的费用(包括使用先进医疗设备的费用)对许多患者来说可能是一大障碍。缺乏广泛的医疗保险覆盖以及与这些治疗相关的自付费用,使得很大一部分人无法负担这些费用。

挑战

  • 监管和报销挑战

越南的监管环境和报销政策可能对介入心脏病学领域的医疗保健提供商构成挑战。简化监管审批和改进报销流程可以促进该市场的增长。

  • 医疗基础设施挑战

尽管越南正在对医疗基础设施进行投资,但部分地区仍面临缺乏先进设备和设施的挑战。这可能会限制复杂手术的实施能力,从而阻碍介入心脏病学市场的增长。

本介入心脏病学市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关介入心脏病学市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

最新动态

  •  2023 年 2 月,IS Medical AG 推出了采用 Twin-Wall 技术的 OPN NC 经皮腔内冠状动脉成形术 (PTCA) 扩张导管。OPN NC 设备的 Twin-Wall 设计具有高压抗性,额定爆破压力为 35 atm,顺应性低
  • 2023 年 1 月,美国 FDA 批准了 Biosensors International 的 BioFreedom 药物涂层冠状动脉支架 (DCS) 系统 P190020。BioFreedom 药物涂层冠状动脉支架系统旨在治疗由冠状动脉疾病引起的血管狭窄(冠状动脉)

越南介入心脏病学市场范围

介入心脏病学市场按类型、产品、适应症、年龄、最终用户和分销渠道进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品

  • 导丝
  • 导管
  • 冠状动脉支架
  • 血管成形术球囊
  • 血管闭合装置 (VCD)
  • 血管内超声 (IVUS)
  • 血流动力学改变装置
  • 瘟疫改造装置
  • 血流储备分数 (FFR)
  • 配件

类型

  • 传统的
  • 先进的

指征

  • 心导管插入术
  • 经皮冠状动脉介入治疗 (PCI)
  • 冠状动脉血栓切除术
  • 斑块切除术
  • 球囊血管成形术
  • 支架植入
  • 低温/主动脉内球囊泵
  • 卵圆孔未闭封堵术
  • 其他的

年龄

  • 成人
  • 老年
  • 儿科

终端用户

  • 医院
  • 导管室
  • 学术及研究机构
  • 其他的

分销渠道

  • 直接招标
  • 第三方分销商
  • 零售销售

医疗保健基础设施增长安装基础和新技术渗透

介入心脏病学市场还为您提供每个国家/地区资本设备医疗支出增长、介入心脏病学市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对介入心脏病学市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和越南介入心脏病学市场份额分析

介入心脏病学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、越南业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对介入心脏病学市场的关注有关。

介入心脏病学市场的一些主要参与者包括:

  • 美敦力(爱尔兰)
  • Teleflex Incorporated(美国)
  • Terumo Vietnam Medical Equipment Co., Ltd(Terumo Corporation 的子公司)(日本)
  • 雅培(美国)
  • 波士顿科学公司 (美国)
  • B.Braun Melsungen AG(德国)
  • USM 医疗保健(新加坡)
  • BIOTRONIK(德国)
  • 史赛克(美国)
  • Philips Electronics NV(Koninjlkjke Philps NV 的子公司)(荷兰)
  • BD(美国)
  • Medinol Ltd.(以色列)
  • AngioDynamics(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Vietnam interventional cardiology device market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. pestel analysis
    2. porters five forces model
    3. CORONARY INTERVENTION CARDIOLOGY (CVI) AND PERIPHERAL VASCULAR INTERVENTION (PVI) PROCEDURE (TOTAL CASES IN VIETNAM), 2019- 2028 (UNIT)
    4. CORONARY INTERVENTION CARDIOLOGY (CVI) AND PERIPHERAL VASCULAR INTERVENTION (PVI) PROCEDURE (CASES IN TOP 10 HOSPITALS), 2019- 2028 (UNIT)
  5. INDUSTRY INSIGHTS
    1. STENT AND BALLOON BUSINESS TRENDS
      1. Overview
  6. VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, REGULATORY FRAMEWORK
    1. VIETNAM
  7. Market Overview
    1. Drivers
      1. high prevalence of cardiovascular diseases
      2. INCREASED RESEARCH AND DEVELOPMENT
      3. RISING GERIATRIC POPULATION
      4. RISE IN THE number of interventional cardiology
      5. RISE IN RATES OF OBESITY
    2. RESTRAINTS
      1. Complications associated with interventional cardiology procedures
      2. High Cost of interventional cardiology products
    3. opportunities
      1. RISE IN EXPENDITURE ON HEALTHCARE
      2. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      3. RISE IN DEMAND FOR MINIMALLY INVASIVE TECHNOLOGY
    4. Challenges
      1. Low awareness for CVD and its interventions
      2. shortage of skilled professionals
  8. IMPACT OF COVID-19 on vietnam interventional cardiology device market
    1. overview
    2. impact on price
    3. impact on demand
    4. Impact on Supply
    5. STRATEGIC DECISIONS of Government and MANUFACTURERS
    6. Conclusion
  9. VIETNAM INTERVENTIONAL CARDIOLOGY DEVICE MARKET, BY product
    1. overview
    2. Catheters
      1. angiography catheters
      2. balloon dilatation catheters
      3. percutaneous transluminal coronary angioplasty (PTCA) guiding catheters
      4. Guide extension catheters
      5. microcatheters
      6. dual lumen catheters
      7. others
    3. guide wires
      1. coronary guide wires
      2. specialty guide wires
    4. coronary stents
      1. bare stents
      2. drug-eluting stents
      3. bio absorbable stents
    5. angioplasty balloons
      1. old/normal balloons
      2. drug-eluting balloons
      3. cutting/scoring balloons
    6. plague modification devices
      1. thrombectomy devices
      2. atherectomy
    7. hemodynamic flow alteration devices
      1. embolic protection devices
      2. chronic total occlusion devices
    8. vascular closure devices (VCDs)
    9. Nitinol clip-based (Starclose) Devices
    10. suture based (perclose)
    11. collagen plug-based (angio-seal)
    12. fractional flow reserve (FFR)
    13. accessories
    14. angioplasty kits
    15. balloon inflation devices
    16. introducer sheaths
    17. hemostasis heart
    18. others
  10. Vietnam interventional cardiology device market, BY type
    1. overview
    2. conventional
      1. catheters
      2. coronary guide wires
      3. coronary stents
      4. vascular closure devices (vcds)
      5. others
    3. advanced
      1. plague modification devices
      2. hemodynamic flow alteration devices
      3. intravascular ultrasound (IVUS) catheters
      4. fractional flow reserve (FFR)
  11. Vietnam interventional cardiology DEVICE MARKET, BY INDICATION
    1. overview
    2. Cardiac Catheterization
    3. Percutaneous Coronary Intervention (PCI)
    4. Coronary Thrombectomy
    5. Atherectomy
    6. Balloon Angioplasty
    7. Stent Implantation
    8. Hypothermia/Intra-Aortic Balloon Pump
    9. Patent Foramen Ovale Closure
    10. Others
  12. VIETNAM INTERVENTIONAL CARDIOLOGY Device MARKET, BY Age
    1. overview
    2. adult
    3. pediatric
    4. geriatric
  13. Vietnam interventional cardiology device market, BY end user
    1. overview
    2. hospitals
      1. acute care hospitals
      2. long-term care hospitals
    3. cath laboratories
    4. Academic & Research institutes
    5. others
  14. Vietnam interventional cardiology device market, BY distribution channel
    1. overview
    2. direct tenders
    3. third party distributors
  15. Vietnam Interventional Cardiology device market: COMPANY landscape
    1. company share analysis: Vietnam
  16. swot analysis
  17. Company profile
    1. BOSTON SCIENTIFIC CORPORATION
      1. COMPANY SNAPSHOT
      2. REVENUE FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. terumo vietnam medical equipments co.,ltd (A subsidiary of terumo corporation)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. mEDTRONIC
      1. COMPANY SNAPSHOT
      2. REVENUE FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Stryker
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. Recent DevelopmentS
    6. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. ANGIO DYNAMICS
      1. COMPANY SNAPSHOT
      2. REVENUE FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. b. braun melsungen ag
      1. cOMPANY SNAPSHOT
      2. revenue analysis
      3. Product Portfolio
      4. 1.8.4 Recent Developments
    9. BIOTRONIK
      1. Company snapshot
      2. Product Portfolio
      3. Recent DevelopmentS
    10. MEDINOL LTD.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Development
    11. phlips electronics n.v. (a subsidiary of koninklijke philips n.v.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. Recent Developments
    12. Teleflex Incorporated
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. USM hEALTHCARE
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Development
  18. questionnaire
  19. related reports

表格列表

TABLE 1 VIETNAM NUMBER OF STENTS USED BY TOP 10 HOSPITALS PER YEAR (2019-2028) (UNITS IN Thousands)

TABLE 2 VIETNAM NUMBER OF BALLOONS USED BY TOP 10 HOSPITALS PER YEAR (2019-2028) (UNITS IN Thousands)

TABLE 3 VIETNAM NUMBER OF STENTS SOLD BY TOP PLAYERS PER YEAR (2019-2028) (UNITS IN Thousands)

TABLE 4 VIETNAM NUMBER OF CATHETERS SOLD BY TOP PLAYERS PER YEAR (2019-2028) (UNITS IN THOUSANDS)

TABLE 5 VIETNAM NUMBER OF BALLOONS SOLD BY TOP PLAYERS PER YEAR (2019-2028) (UNITS IN THOUSANDS)

TABLE 6 VIETNAM INTERVENTION CARDIOLOGY (CVI) CASES (CASES IN THOUSANDS)

TABLE 7 VIETNAM INTERVENTION CARDIOLOGY (CVI) CASES (CASES IN THOUSANDS)

TABLE 8 VIETNAM PERIPHERAL VASCULAR INTERVENTION (PVI) CASES (CASES IN THOUSANDS)

TABLE 9 Product Classification:

TABLE 10 Most obese countries of Asia-Pacific IN 2020

TABLE 11 Prices of medical devices

TABLE 12 Vietnam interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 13 Vietnam catheters in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 14 Vietnam guide wires in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 15 Vietnam coronary stents in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 16 Vietnam angioplasty balloons in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 17 Vietnam plague modification devices in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 18 Vietnam hemodynamic flow alteration devices in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 19 Vietnam vascular closure devices (VCDs) in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 20 Vietnam accessories in interventional cardiology device market, By product, 2019-2028 (USD MILLION)

TABLE 21 Vietnam interventional cardiology device market, By type, 2019-2028 (USD MILLION)

TABLE 22 Vietnam conventional in interventional cardiology device market, By type, 2019-2028 (USD MILLION)

TABLE 23 Vietnam advanced in interventional cardiology device market, By type, 2019-2028 (USD MILLION)

TABLE 24 Vietnam interventional cardiology DEVICE Market, By INDICATION, 2019-2028 (USD MILLION)

TABLE 25 Vietnam interventional cardiology device market, By age, 2019-2028 (USD MILLION)

TABLE 26 Vietnam interventional cardiology device market, By end user, 2019-2028 (USD MILLION)

TABLE 27 Vietnam hospitals in interventional cardiology device market, By end user, 2019-2028 (USD MILLION)

TABLE 28 Vietnam interventional cardiology device market, By distribution channel, 2019-2028 (USD MILLION)

图片列表

FIGURE 1 Vietnam interventional CARDIOLOGY DEVICE MARKET: segmentation

FIGURE 2 Vietnam interventional CARDIOLOGY DEVICE MARKET: data triangulation

FIGURE 3 Vietnam interventional CARDIOLOGY DEVICE MARKET: DROC ANALYSIS

FIGURE 4 Vietnam interventional CARDIOLOGY DEVICE MARKET: REGIONAL VS COUNTRY ANALYSIS

FIGURE 5 Vietnam interventional CARDIOLOGY DEVICE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 Vietnam interventional CARDIOLOGY DEVICE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 Vietnam interventional CARDIOLOGY DEVICE MARKET: DBMR MARKET POSITION GRID

FIGURE 8 Vietnam interventional CARDIOLOGY DEVICE MARKET: end user COVERAGE GRID

FIGURE 9 Vietnam interventional CARDIOLOGY DEVICE MARKET: vendor share analysis

FIGURE 10 Vietnam interventional CARDIOLOGY DEVICE MARKET: SEGMENTATION

FIGURE 11 THE increasing prevalence of cardiovascular diseases is expected to drive THE Vietnam interventional CARDIOLOGY DEVICE MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 Product segment is expected to account for the largest share of the Vietnam interventional CARDIOLOGY DEVICE MARKET in 2021 & 2028

FIGURE 13 DRIVERS, restraints, opportunities, and challenges OF Vietnam interventional CARDIOLOGY DEVICE MARKET

FIGURE 14 Ageing population of VIEtnam

FIGURE 15 Vietnam interventional cardiology device market: BY product,2020

FIGURE 16 Vietnam interventional cardiology device market: BY product, 2021-2028 (USD MILLION)

FIGURE 17 Vietnam interventional cardiology device market: BY product, CAGR (2021-2028)

FIGURE 18 Vietnam interventional cardiology device market: BY product, LIFELINE CURVE

FIGURE 19 Vietnam interventional cardiology device market : BY type, 2020

FIGURE 20 Vietnam interventional cardiology device market : BY type, 2021-2028 (USD MILLION)

FIGURE 21 Vietnam interventional cardiology device market : BY type, CAGR (2021-2028)

FIGURE 22 Vietnam interventional cardiology device market: BY type, LIFELINE CURVE

FIGURE 23 Vietnam interventional cardiology DEVICE MARKET : BY INDICATION, 2020

FIGURE 24 Vietnam interventional cardiology DEVICE MARKET: BY INDICATION, 2021-2028 (USD MILLION)

FIGURE 25 Vietnam interventional cardiology DEVICE MARKET: BY INDICATION, CAGR (2021-2028)

FIGURE 26 Vietnam interventional cardiology DEVICE MARKET: BY INDICATION, LIFELINE CURVE

FIGURE 27 Vietnam interventional cardiology device market: BY age, 2020

FIGURE 28 Vietnam interventional cardiology device market: BY age, 2021-2028 (USD MILLION)

FIGURE 29 Vietnam interventional cardiology device market: BY age, CAGR (2021-2028)

FIGURE 30 Vietnam interventional cardiology device market: BY age, LIFELINE CURVE

FIGURE 31 Vietnam interventional cardiology device market : BY end user, 2020

FIGURE 32 Vietnam interventional cardiology device market : BY end user, 2021-2028 (USD MILLION)

FIGURE 33 Vietnam interventional cardiology device market : BY end user, CAGR (2021-2028)

FIGURE 34 Vietnam interventional cardiology device market: BY end user, LIFELINE CURVE

FIGURE 35 Vietnam interventional cardiology device market : BY distribution channel, 2020

FIGURE 36 Vietnam interventional cardiology device market : BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 37 Vietnam interventional cardiology device market : BY distribution channel, CAGR (2021-2028)

FIGURE 38 Vietnam interventional cardiology device market: BY distribution channel, LIFELINE CURVE

FIGURE 39 Vietnam Interventional CARDIOLOGY DEVICE MARKET: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The type, product, indication, age, end user, and distribution channel are the factors on which the Vietnam Interventional Cardiology Market research is based.
The major companies in the Vietnam Interventional Cardiology Market are Medtronic (Ireland), Teleflex Incorporated (U.S.), Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation) (Japan), Abbott (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), USM HEALTHCARE (Singapore), BIOTRONIK (Germany), Stryker (U.S.), Philips Electronics N.V. (A subsidiary of Koninjlkjke Philps NV) (Netherlands), BD (U.S.), Medinol Ltd. (Israel), AngioDynamics (U.S.).
The Increasing cardiovascular disease burden, Advancements in medical technology, Government initiatives, and healthcare investments are the growth drivers of the Vietnam Interventional Cardiology Market.
The Vietnam Interventional Cardiology Market growth rate is 6.80% during the forecast period by 2031.
The latest developments in the Vietnam Interventional Cardiology Market are Medical AG's launched OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology and U.S. FDA approved the BioFreedom Drug Coated Coronary Stent (DCS) System P190020 from Biosensors International.